GILLIS EDWARD M 4
4 · BioCardia, Inc. · Filed Apr 18, 2022
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
GILLIS EDWARD M
Senior Vice President, Devices
Transactions
- Award
Stock Option (right to buy)
2022-04-14+38,000→ 38,000 totalExercise: $1.49Exp: 2032-04-14→ Common Stock (38,000 underlying) - Award
Common Stock
2022-04-14+30,155→ 36,237 total
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
- [F2]The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.